Micro-X Limited (ASX: MX1)
Australia
· Delayed Price · Currency is AUD
0.0800
-0.0050 (-5.88%)
Dec 27, 2024, 11:10 AM AEST
Micro-X Revenue
In the fiscal year ending June 30, 2024, Micro-X had annual revenue of 15.22M AUD with 1.45% growth. Micro-X had revenue of 7.03M in the half year ending June 30, 2024, with 6.21% growth.
Revenue
15.22M
Revenue Growth
+1.45%
P/S Ratio
2.77
Revenue / Employee
n/a
Employees
n/a
Market Cap
46.53M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 15.22M | 217.00K | 1.45% |
Jun 30, 2023 | 15.01M | 6.04M | 67.28% |
Jun 30, 2022 | 8.97M | 5.20M | 137.87% |
Jun 30, 2021 | 3.77M | -480.00K | -11.29% |
Jun 30, 2020 | 4.25M | 2.32M | 120.15% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 22.18B |
ResMed Inc. | 6.93B |
Pro Medicus Limited | 161.50M |
Fisher & Paykel Healthcare Corporation Limited | 1.74B |
Cochlear Limited | 2.24B |
Sonic Healthcare Limited | 8.97B |
Telix Pharmaceuticals Limited | 645.68M |
Ramsay Health Care Limited | 16.66B |